High Content Screening Market By Product Type (Instruments, Software), By Application (Target Identification And Validation, Primary And Secondary Screening), By End-User (Pharmaceutical And Healthcare, Biotechnology), And Region For 2024-2031
Report ID: 24081|No. of Pages: 202
High Content Screening Market By Product Type (Instruments, Software), By Application (Target Identification And Validation, Primary And Secondary Screening), By End-User (Pharmaceutical And Healthcare, Biotechnology), And Region For 2024-2031
High Content Screening Market Valuation – 2024-2031
The High Content Screening (HCS) Market this tendency is fueled by a number of fundamental causes. First, the pharmaceutical and academic research sectors are expanding, creating a greater demand for efficient drug discovery and development technologies. HCS glows in this field because it provides extensive information on cellular activities and medication responses.
HCS instruments are becoming more advanced, with greater automation and data analysis capabilities. The market size surpass USD 910.88 Million valued in 2023 to reach a valuation of around USD 1702.29 Million by 2031.
Furthermore, software advancements enable researchers to extract even more valuable insights from the high-resolution images produced by HCS devices. This combination of variables makes HCS an increasingly appealing choice for researchers looking for a more efficient and comprehensive approach to drug development and biological examination. The rising demand for cost-effective and efficient high content screening is enabling the market grow at a CAGR of 8.13% from 2024 to 2031.
>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=24081
High Content Screening Market: Definition/ Overview
High content screening (HCS), also known as high content analysis (HCA), is a biological research and drug discovery tool that uses automated microscopy and advanced image analysis to collect and evaluate massive volumes of data from cell populations. It seeks to extract quantitative data from biological events and processes such as changes in gene expression, protein localization, and interactions. HCS provides a comprehensive perspective of cellular responses by allowing various biological parameters to be monitored simultaneously within the same experiment, making it easier to identify prospective drug candidates and better understand cellular mechanisms.
It is often used for phenotypic screening, which identifies prospective therapeutic candidates by examining biological responses to different chemicals. HCS is particularly important in toxicology investigations since it helps analyze the safety and potential adverse effects of chemicals and medications on cells. HCS aids cancer research by understanding drug resistance processes and identifying novel therapeutic targets.
HCS includes integration with new technologies such as artificial intelligence and machine learning, which will enhance its analytical skills, allowing for more precise and complete investigation of complex biological systems. Furthermore, advances in imaging modalities and data processing will broaden the uses of HCS, making it a must-have tool in personalized medicine, regenerative therapies, and precision oncology.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24081
How do the Increasing Drug Discovery and Development Efforts Drive the High Content Screening Market?
In the high content screening (HCS) market, increased drug discovery and development efforts will be fueled. As pharmaceutical companies focus on discovering novel drugs, the demand for enhanced screening technologies such as HCS increases. The US Food and Drug Administration (FDA) has reported an ongoing rise in novel drug approvals, with the FDA’s Center for Drug Evaluation and Research (CDER) approving 53 innovative drugs in 2020, up from 48 in 2019 and 59 in 2018. This increased trend reflects the growing demand for advanced screening technologies like as HCS to improve the drug discovery process, underlining its vital role in identifying and developing novel therapeutic agents.
The increase in global frequency of chronic diseases is rising the demand for more effective drug development strategies, such as high-content screening (HCS). According to the World Health Organization (WHO), chronic diseases account for 71% of all deaths worldwide, killing 41 million people each year. This disturbing number emphasizes the critical need for new and effective treatments, which is fueling the growth of the HCS market as researchers and pharmaceutical companies seek advanced technologies to accelerate the discovery and development of therapeutic solutions for these common health problems.
How Does Data Management and Analysis Affect the High Content Screening Market?
Data management and analysis will have significant effects on the high content screening (HCS) market. HCS creates massive amounts of complex data, necessitating powerful data management and analysis techniques to extract useful insights. Efficient data handling is critical for accurately interpreting results, identifying patterns, and making sound judgments in drug discovery and biological research. As the volume and complexity of HCS data increases, so does the demand for strong data management solutions and sophisticated analytic methods. Improvements in these areas will not only increase the efficiency and accuracy of HCS but will also drive its market adoption and expansion.
Standardization challenges will have an impact on the high content screening (HCS) market. The absence of established techniques and data processing methodologies can cause variability in results, affecting the comparison and accuracy of findings across research and laboratories. Addressing these issues is critical to achieving consistency, which is required for the wider use and integration of HCS in drug discovery and biomedical research. Improved standards will improve data quality and interoperability, resulting in increased growth and efficacy for the HCS business.
The use of a high number of cells in HCS creates ethical issues about animal suffering. Researchers are continually advocating for the development of more efficient and ethical screening procedures.
Category-Wise Acumens
Will Increase in Automation Propel the Instruments Segment for the High Content Screening Market?
The instruments category dominates the high-content screening market. Increase in automation will drive the instruments segment of the high content screening (HCS) market. Automation improves the efficiency, accuracy, and throughput of HCS procedures by reducing manual involvement and the risk of human mistakes. This allows for faster data capture and analysis, resulting in high-throughput screening of huge compound libraries. As pharmaceutical and research laboratories attempt to streamline workflows and increase productivity, demand for advanced automated HCS instruments will rise, propelling the market segment forward.
Improved image quality will propel the instruments segment of the high content screening (HCS) market. High-resolution, high-contrast images are essential for precisely analyzing biological responses and obtaining detailed quantitative data. Improved image quality enables more exact identification of cellular characteristics and minor phenotypic changes, hence increasing the reliability and robustness of HCS results. As researchers and pharmaceutical companies seek higher accuracy and deeper insights in their studies, demand for sophisticated HCS instruments with improved imaging capabilities will rise, driving growth in this market segment.
Will Drug Discovery Focus Raise the Pharmaceutical & Healthcare Segment For the High Content Screening Market?
The pharmaceutical & healthcare sector currently holds the dominant position within the high content screening (HCS) market. The pharmaceutical and healthcare segments of the high content screening (HCS) market will benefit from a greater emphasis on drug discovery. Pharmaceutical companies are using HCS to identify and optimize prospective medication candidates as they ramp up their attempts to create new medicines for diverse diseases. HCS allows for thorough analysis of biological responses and the research of disease causes, ultimately aiding medication discovery and development efforts. As demand for new therapies rises, HCS’s significance in promoting personalized medicine and improving healthcare outcomes will grow, propelling this market segment further.
High research investment will boost the pharmaceutical and healthcare sectors of the high content screening (HCS) market. Increased financing enables substantial research efforts targeted at discovering new medicines and better understanding of illness causes. HCS contributes significantly to these efforts by allowing for a thorough investigation of cellular responses and the screening of prospective medication candidates. As research funding increases, particularly in areas such as oncology, neuroscience, and personalized medicine, demand for advanced HCS technologies will rise, driving growth in the pharmaceutical and healthcare sectors of the market.
Gain Access into High Content Screening Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=24081
Country/Region-wise Acumens
Will Pharmaceutical & Biotechnology Presence Boom the High Content Screening Market in North America?
North America currently holds the dominant position in the high content screening (HCS) market. North America has a strong pharmaceutical and biotechnology industry, which plays an important role in encouraging the adoption of High Content Screening (HCS) technologies. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry will invest around $102.3 billion in research and development in 2021, with a strong emphasis on drug discovery techniques that use HCS.
Furthermore, the US Food and Drug Administration (FDA) approved 50 new pharmaceuticals in 2021, demonstrating the region’s commitment to breakthrough therapies. This significant R&D expenditure and high rate of medication approvals show the importance of advanced screening technologies such as HCS in developing the North American life sciences sector, supporting market growth and advancements in the field.
North America has a long tradition of early acceptance and invention in life science technology, such as High Content Screening. The National Institutes of Health (NIH) reports a considerable increase in research programs utilizing high-throughput screening technologies, including HCS, with over 1,200 projects funded in fiscal year 2020, up from about 800 in 2015, representing a 50% increase in just five years. This significant investment and rapid adoption of advanced screening technologies has resulted in a strong infrastructure and expertise basis for HCS in North America, fostering continued market expansion and technological advancement in this industry.
Will the Rapid Economic Growth of the Asian Pacific Boost the High Content Screening Market?
The Asia Pacific region is experiencing the fastest growth in the HCS market. Rapid economic growth in the Asia-Pacific area is driving up investment in life sciences research and development, especially in advanced technologies such as High Content Screening (HCS). Despite global economic concerns, developing economies in Asia and the Pacific are expected to grow by 4.8% in 2023 and 4.9% in 2024, according to the Asian Development Bank.
This economic momentum is driving significant financing into HCS, as evidenced by the Japan Agency for Medical Research and Development (AMED), which has earmarked 126.1 billion yen (about USD 1.15 billion) in fiscal year 2021 for drug discovery and development initiatives that use HCS technologies. These investments, combined with the increased emphasis on life sciences research, are likely to greatly enhance the acceptance and expansion of the HCS market in Asia-Pacific.
Government initiatives in the Asia-Pacific area are essential in promoting advances in healthcare and life sciences, with a considerable impact on the adoption of High Content Screening (HCS) technology. China’s 14th Five-Year Plan (2021-2025) promotes the biotechnology sector, with significant sums set aside for medication discovery and development.
The Chinese Ministry of Science and Technology plans to expand R&D investment to more than 2.5% of GDP by 2025, with a concentration on life sciences. Similarly, India’s Department of Biotechnology has earmarked Rs. 2,581 crore (about $350 million USD) for fiscal year 2021-2022 to support biotechnology research and innovation. These government-led activities are creating a favorable environment for the adoption of advanced screening technologies such as HCS, hence driving market expansion throughout the region.
Competitive Landscape
The high content screening market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.
The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the high content screening market include:
PerkinElmer Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, BD (Becton, Dickinson and Company), GE Healthcare, Tecan Group, BioTek Instruments Inc., Yokogawa Electric Corporation, Merck Millipore
Latest Developments
- In November 2022, a particle engineering business launched the Automated Library Synthesis (ALS) System. This platform encourages medicine synthesis automation and high-throughput evaluation of lipid nanoparticle (LNP) formulations and mRNA candidates.
- In December 2022, PhoreMost, a new-model drug discovery company based in Cambridge, U.K., and a Japan-based firm specializing in the discovery of novel high-value therapeutic cells and therapeutic cells, formed a strategic research agreement to advance current phenotypic drug screening through the use of artificial intelligence (Al).
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2018-2031 |
| Growth Rate | CAGR of ~8.13% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | 2018-2022 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Million |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players |
|
| Customization | Report customization along with purchase available upon request |
High Content Screening Market, By Category
Product Type:
- Instruments
- Software
- Consumables
- Services
Application:
- Target Identification and Validation
- Primary and Secondary Screening
- Toxicity Studies
- Compound Profiling
End-User:
- Pharmaceutical & Healthcare
- Biotechnology
- Educational Institutions
- Independent CRO
- Government Organizations
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report:
Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
1 INTRODUCTION OF GLOBAL HIGH CONTENT SCREENING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HIGH CONTENT SCREENING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
5 GLOBAL HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE
5.1 Overview
5.2 Instruments
5.3 Software
5.4 Consumables
5.5 Services
6 GLOBAL HIGH CONTENT SCREENING MARKET, BY APPLICATION
6.1 Overview
6.2 Target Identification and Validation
6.3 Primary and Secondary Screening
6.4 Toxicity Studies
6.5 Compound Profiling
7 GLOBAL HIGH CONTENT SCREENING MARKET, BY END-USER
7.1 Overview
7.2 Pharmaceutical & Healthcare
7.3 Biotechnology
7.4 Educational Institutions
7.5 Independent CRO
7.6 Government Organizations
8 GLOBAL HIGH CONTENT SCREENING MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East & Africa
9 GLOBAL HIGH CONTENT SCREENING MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 PerkinElmer, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Danaher Corporation
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Thermo Fisher Scientific, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Agilent Technologies
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 BD (Becton, Dickinson and Company)
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 GE Healthcare
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Tecan Group
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 BioTek Instruments, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Merck Millipore
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Yokogawa Electric Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 KEY DEVELOPMENTS
11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations
12 Appendix
12.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
